Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2735 (LINC02735) is a member of the lincRNA family, a subtype of long non-coding RNAs (lncRNAs) characterized by being longer than 200 nucleotides and not overlapping protein-coding genes[1][5]. lincRNAs generally function in the nucleus and play roles in the regulation of gene expression, chromatin architecture, and may influence immune processes and tumor microenvironment[3][5]. LINC02735 has emerged in bioinformatic analyses as potentially relevant in immune-related processes and may serve as a marker for the molecular subtyping of cancers such as head and neck squamous cell carcinoma, though its precise biological functions and therapeutic potential require further research[2]. There are currently no known direct drug interactions or validated mechanisms of action for LINC02735.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2735 (LINC02735).